Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income: 2018-2025

Historic Other Non Operating Income for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to $3.2 million.

  • Arcturus Therapeutics Holdings' Other Non Operating Income fell 15.30% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year decrease of 26.17%. This contributed to the annual value of $15.2 million for FY2024, which is 55.25% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Other Non Operating Income stood at $3.2 million for Q3 2025, which was up 25.98% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Other Non Operating Income ranged from a high of $34.0 million in Q1 2023 and a low of -$3.8 million during Q4 2022.
  • In the last 3 years, Arcturus Therapeutics Holdings' Other Non Operating Income had a median value of $3.5 million in 2023 and averaged $6.5 million.
  • In the last 5 years, Arcturus Therapeutics Holdings' Other Non Operating Income tumbled by 2,281.82% in 2021 and then skyrocketed by 6,120.04% in 2023.
  • Arcturus Therapeutics Holdings' Other Non Operating Income (Quarterly) stood at -$524,000 in 2021, then tumbled by 631.87% to -$3.8 million in 2022, then soared by 113.80% to $4.0 million in 2023, then fell by 4.09% to $3.2 million in 2024, then declined by 15.30% to $3.2 million in 2025.
  • Its Other Non Operating Income was $3.2 million in Q3 2025, compared to $2.6 million in Q2 2025 and $2.8 million in Q1 2025.